of0
Export
 
CDE Detailed Report
This report contains detailed information about the selected CDEs.
Note: If at least one CDE was selected from a copyright- or trademark-protected instrument/scale then all of the CDEs from that instrument/scale are included in this report.
Disease: Stroke
Sub-Domain: Drugs
CRF: Antithrombotics and Risk Factor Controlling Medications
Item count: 15 (15 distinct CDEs)
CDE ID
CDE Name
Variable Name
Definition / Description
Question Text
Permissible Value
Description
Data Type
Instructions
References
Population
Classification (e.g., Core)
Version #
Version Date
Aliases for Variable Name
CRF Module / Guideline
© or TM
Sub-Domain
Domain
Previous Title
Size
Input Restrictions
Min Value
Max Value
Measurement Type
LOINC ID
SNOMED
caDSR ID
CDISC ID
C14631
Antiplatelet in hospital indicator
AntiplatelHospInd
Whether the participant/ subject received arterial dose antiplatelets during the acute hospital stay
Did the participant/subject receive arterial dose antiplatelets
Yes;No;Unknown;
Yes;No;Unknown;
Alphanumeric
Choose one

Supplemental - Highly Recommended based on study type, disease stage and disease type
No references available
Adult;Pediatric
Supplemental–Highly Recommended
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
Antiplatelet in hospital indicator
 
Single Pre-Defined Value Selected
       
C14632
Antiplatelet type
AntiplatTyp
Type(s) of antiplatelets received
Type(s) of antiplatelets received
Aspirin;Aspirin/Dipyridamole (in separate formulations or as Aggrenox);Clopidogrel (Plavix);Ticlopidine (Ticlid);Other, specify;
Aspirin;Aspirin/Dipyridamole (in separate formulations or as Aggrenox);Clopidogrel (Plavix);Ticlopidine (Ticlid);Other, specify;
Alphanumeric
Choose all that apply.

Supplemental - Highly Recommended based on study type, disease stage and disease type
Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry
Adult;Pediatric
Supplemental–Highly Recommended
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
Antiplatelet type
 
Multiple Pre-Defined Values Selected
       
C14630
Anticoagulant type
AnticoagTyp
Type(s) of anticoagulants received
Type(s) of anticoagulants received
Unfractionated heparin IV;Full dose LMW heparin (Enoxaparin , Others);Warfarin (Coumadin);Fondaparinux (Arixtra);Other, specify;
Unfractionated heparin IV;Full dose LMW heparin (Enoxaparin , Others);Warfarin (Coumadin);Fondaparinux (Arixtra);Other, specify;
Alphanumeric
Choose all that apply.

Supplemental - Highly Recommended based on study type, disease stage and disease type
Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry
Adult;Pediatric
Supplemental–Highly Recommended
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
Anticoagulant type
 
Multiple Pre-Defined Values Selected
       
C14629
Anticoagulant in hospital indicator
AnticoagHospInd
Whether the participant/ subject received arterial dose anticoagulants during the acute hospital stay, not including venous prophylaxis dose Unfractionated heparin, LMW heparin, etc.
Did the participant/subject receive arterial dose anticoagulants
Yes;No;Unknown;
Yes;No;Unknown;
Alphanumeric
Choose one

Supplemental - Highly Recommended based on study type, disease stage and disease type
Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009)
Adult;Pediatric
Supplemental–Highly Recommended
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
Anticoagulant in hospital indicator
 
Single Pre-Defined Value Selected
       
C18984
Anticoagulant other text
AnticoagOTH
The free-text field related to 'Anticoagulant type' specifying other text. Type(s) of anticoagulants received
Other, specify
  
Alphanumeric
Choose all that apply.

Supplemental - Highly Recommended based on study type, disease stage and disease type
Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry
Adult;Pediatric
Supplemental–Highly Recommended
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
 
4000
Free-Form Entry
       
C18985
Antiplatelet other text
AntiplatOTH
The free-text field related to 'Antiplatelet type' specifying other text. Type(s) of antiplatelets received
Other, specify
  
Alphanumeric
Choose all that apply.

Supplemental - Highly Recommended based on study type, disease stage and disease type
Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry
Adult;Pediatric
Supplemental–Highly Recommended
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
 
4000
Free-Form Entry
       
C14633
Extracranial venous thromboembolism indicator
ExtraVenThromInd
Whether the participant/ subject was diagnosed with an extracranial venous thromboembolism (VTE)
Was the participant/subject diagnosed with VTE
Yes;No;Unknown;
Yes;No;Unknown;
Alphanumeric
Choose one
No references available
Adult;Pediatric
Supplemental
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
Extracranial venous thromboembolism indicator
 
Single Pre-Defined Value Selected
       
C14634
Extracranial venous thromboembolism type
ExtraCranVenThromTyp
Type(s) of extracranial venous thromboembolism (VTE) diagnosed with
Diagnosis with which type(s)
Deep venous thrombosis (DVT);Pulmonary embolism;Other, specify;
Deep venous thrombosis (DVT);Pulmonary embolism;Other, specify;
Alphanumeric
Choose all that apply.
No references available
Adult;Pediatric
Supplemental
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
Extracranial venous thromboembolism type
 
Multiple Pre-Defined Values Selected
       
C18986
Extracranial venous thromboembolism other text
ExtraCranVenThromOTH
The free-text field related to 'Extracranial venous thromboembolism type' specifying other text. Type(s) of extracranial venous thromboembolism (VTE) diagnosed with
Other, specify
  
Alphanumeric
Choose all that apply.
No references available
Adult;Pediatric
Supplemental
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
 
4000
Free-Form Entry
       
C18987
Extracranial venous thromboembolism prophylaxis other text
ExtraCranVenThromProphylOTH
The free-text field related to 'Extracranial venous thromboembolism prophylaxis type' specifying other text. Type(s) of extracranial venous thromboembolism (VTE) prophylaxis used
Type(s) of VTE prophylaxis used
  
Alphanumeric
Choose all that apply.
CMS/ The Joint Commission: SCIP-VTE-1, SCIP-VTE-2; The Joint Commission Only: STK-1, VTE-1
Adult;Pediatric
Supplemental
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
 
4000
Free-Form Entry
       
C14635
Extracranial venous thromboembolism prophylaxis type
ExtraCranVenThromProphylTyp
Type(s) of extracranial venous thromboembolism (VTE) prophylaxis used
Type(s) of VTE prophylaxis used
Low dose unfractionated heparin (LDUH);Low molecular weight heparin (LMWH);Intermittent pneumatic compression devices (IPC);Factor Xa Inhibitor;Warfarin;Venous foot pumps (VFP);Oral Factor Xa inhibitor;Other, specify;
"regular" heparin;enoxaparin, dalteparin, nadroparin, danaparoid, heparinoids, etc.;;;Warfarin;Venous foot pumps (VFP);;;
Alphanumeric
Choose all that apply.
CMS/ The Joint Commission: SCIP-VTE-1, SCIP-VTE-2; The Joint Commission Only: STK-1, VTE-1
Adult;Pediatric
Supplemental
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
Extracranial venous thromboembolism prophylaxis type
 
Multiple Pre-Defined Values Selected
       
C14636
Heparin venous thromboembolism (VTE) prophylaxis dose
HeparinVenThrombembProphDose
Dose of heparin used to treat the extracranial venous thromboembolism (VTE), including the units for dose
Provide dose
  
Numeric Values
Indicate the numeric dose along with its unit of measurement.
No references available
Adult;Pediatric
Supplemental
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
Heparin VTE prophylaxis dose
 
Free-Form Entry
       
C14637
Stroke discharge medication category
StrokDisMedCat
Class(es) of medications the participant/ subject was prescribed at hospital discharge following stroke
Which class(es) of medications was the participant/subject prescribed at hospital discharge
Anticoagulants;Antiplatelets;Antihypertensives;Anti-diabetic agents;Lipid lowering agents;
Anticoagulants;Antiplatelets;Antihypertensives;Anti-diabetic agents;Lipid lowering agents;
Alphanumeric
Choose all that apply

Supplemental - Highly Recommended based on study type, disease stage and disease type
No references available
Adult;Pediatric
Supplemental–Highly Recommended
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
Stroke discharge medication category
 
Multiple Pre-Defined Values Selected
       
C14638
Antithrombotic therapy not prescribed reason
AntithromTherNotPresRsn
Reason(s) for not prescribing antithrombotic therapy (i.e., no anticoagulants or antiplatelets), documented by a physician, advance practice nurse or physician assistant.
Reason(s) antithrombotic therapy was not prescribed at hospital discharge
Allergy to or complication related to aspirin, ticlopidine, clopidogrel, dipyridamole, warfarin or heparins (history or current);Patient/Family refused;Risk for bleeding or discontinued due to bleeding;Serious side effect to medication;Terminal illness/Comfort measures only;Other, specify;
Allergy to or complication related to aspirin, ticlopidine, clopidogrel, dipyridamole, warfarin or heparins (history or current);Patient/Family refused;Risk for bleeding or discontinued due to bleeding;Serious side effect to medication;Terminal illness/Comfort measures only;Other, specify;
Alphanumeric
Choose all that apply. If reasons are not mentioned in the context of antithrombotics, do not make inferences (e.g., do not assume that antithrombotics are not being prescribed because of a bleeding disorder unless documentation explicitly states so).
Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry
Adult;Pediatric
Supplemental
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
Antithrombotic therapy not prescribed reason
 
Multiple Pre-Defined Values Selected
       
C18988
Antithrombotic therapy not prescribed other text
AntithromTherNotPresOTH
The free-text field related to 'Antithrombotic therapy not prescribed reason' specifying other text. Reason(s) for not prescribing antithrombotic therapy (i.e., no anticoagulants or antiplatelets), documented by a physician, advance practice nurse or physician assistant.
Other, specify
  
Alphanumeric
Choose all that apply. If reasons are not mentioned in the context of antithrombotics, do not make inferences (e.g., do not assume that antithrombotics are not being prescribed because of a bleeding disorder unless documentation explicitly states so).
Get With The Guidelines (GWTG) Stroke Patient Management Tool Coding Instructions (Updated on 11/4/2009); Paul Coverdell National Acute Stroke Registry
Adult;Pediatric
Supplemental
3.0
6/21/2013
Aliases for variable name not defined
Antithrombotics and Risk Factor Controlling Medications
Drugs
Treatment/Intervention Data
 
4000
Free-Form Entry
       
01-16-2019
Page 1 of 1